Log in

NYSE:SMA - Symmetry Medical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$13,000.00
0.00 (0.00 %)
(As of 10/17/2019)
Add
Today's Range
$13,000.00
Now: $13,000.00
$13,000.00
50-Day Range
$13,350.00
MA: $15,947.00
$16,000.00
52-Week Range N/A
Volume80 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
CUSIP87154620
WebN/A
Phone+1-574-2682252

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SMA News and Ratings via Email

Sign-up to receive the latest news and ratings for SMA and its competitors with MarketBeat's FREE daily newsletter.


Symmetry Medical (NYSE:SMA) Frequently Asked Questions

What is Symmetry Medical's stock symbol?

Symmetry Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "SMA."

Has Symmetry Medical been receiving favorable news coverage?

Media stories about SMA stock have trended neutral recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Symmetry Medical earned a news impact score of 0.2 on InfoTrie's scale. They also gave headlines about the healthcare company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Symmetry Medical.

Who are some of Symmetry Medical's key competitors?

What other stocks do shareholders of Symmetry Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Symmetry Medical investors own include Consort Medical (CSRT), Newcrest Mining (NCM), Petrel Resources (PET), Achillion Pharmaceuticals (ACHN), Alphabet (GOOG), Illumina (ILMN), AmerisourceBergen (ABC), Boeing (BA), Altaba (AABA) and Rambler Metals and Mining (RMM).

Who are Symmetry Medical's key executives?

Symmetry Medical's management team includes the folowing people:
  • Thomas W. Barrett, Senior Vice President and Chief Commercial Officer - OEM Solutions
  • Christopher G. Cummins, Senior Vice President, Chief Manufacturing Officer - OEM Solutions (Age 44)
  • Stephen Hinora Jr., Senior Vice President - Quality Assurance/Regulatory Affairs (Age 53)

What is Symmetry Medical's stock price today?

One share of SMA stock can currently be purchased for approximately $13,000.00.

How can I contact Symmetry Medical?

Symmetry Medical's mailing address is 3724 N STATE ROAD 15, WARSAW, IN 46582, United States. The healthcare company can be reached via phone at +1-574-2682252.


MarketBeat Community Rating for Symmetry Medical (NYSE SMA)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  175
MarketBeat's community ratings are surveys of what our community members think about Symmetry Medical and other stocks. Vote "Outperform" if you believe SMA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SMA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel